Annualized Relapse Rate of First-Line Treatments for Multiple Sclerosis: A Meta-Analysis, Including Indirect Comparisons Versus Fingolimod (P01.136)
Year: 2012
Type: conference-abstract
Source: Neurology
Authors: D. Tyas, N. Roskell, E. Zimovetz, C. Rycroft, B. Eckert
Institutions: Novartis (United Kingdom), RTI Health Solutions
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: relapsing-remitting multiple sclerosis, annualized relapse rate, fingolimod, interferon-beta, glatiramer acetate, disease-modifying therapy, first-line therapy, indirect comparison, network meta-analysis, relapse prevention, interferon beta-1a, interferon beta-1b, treatment effect heterogeneity
Open Access status: closed
OpenAlex ID: W2017672736
